Lebenthal Global Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.01M Sell
5,720
-29
-0.5% -$10.3K 0.29% 60
2025
Q4
$1.88M Sell
5,749
-964
-14% -$306K 0.29% 57
2025
Q3
$1.89M Buy
6,713
+814
+14% +$236K 0.33% 52
2025
Q2
$1.65M Buy
5,899
+824
+16% +$233K 0.31% 50
2025
Q1
$1.58M Buy
5,075
+77
+2% +$22.7K 0.3% 42
2024
Q4
$1.3M Buy
4,998
+1,546
+45% +$459K 0.24% 66
2024
Q3
$1.11M Sell
3,452
-119
-3% -$38.9K 0.23% 64
2024
Q2
$1.12M Buy
3,571
+151
+4% +$44.4K 0.24% 56
2024
Q1
$972K Sell
3,420
-135
-4% -$39.5K 0.22% 54
2023
Q4
$1.02M Buy
3,555
+750
+27% +$204K 0.24% 51
2023
Q3
$754K Buy
2,805
+27
+1% +$6.74K 0.23% 51
2023
Q2
$617K Sell
2,778
-56
-2% -$13K 0.18% 60
2023
Q1
$685K Buy
+2,834
New +$696K 0.21% 46
2021
Q2
Sell
-943
Closed -$234K 160
2021
Q1
$234K Buy
943
+908
+2,594% +$217K 0.14% 119
2020
Q4
$8K Buy
+35
New +$8.07K 0.01% 450

Other funds holding AMGN

Lebenthal Global Advisors's AMGN Position: Q1 2026 in Review

Lebenthal Global Advisors reduced its Amgen (AMGN) stake by 0.5% in Q1 2026, selling an estimated $10.3K and leaving 5,720 shares worth $2.01M. The position accounts for 0.29% of the portfolio, ranked #60.

Lebenthal Global Advisors first reported a position in AMGN in Q4 2020 and has held it in 15 quarters since. 3,126 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Lebenthal Global Advisors held 5,720 shares of Amgen worth $2.01M as of Q1 2026.
  • Lebenthal Global Advisors sold 29 Amgen shares in Q1 2026, an estimated $10.3K.
  • Amgen made up 0.29% of Lebenthal Global Advisors's portfolio in Q1 2026, its #60 holding.
  • Lebenthal Global Advisors first reported a position in Amgen in Q4 2020 and has held it in 15 quarters since.
  • 3,126 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Lebenthal Global Advisors's 13F filing for Q1 2026, filed 14 May 2026.